Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03912363 · ClinicalTrials.gov registry record · NA

Intrapartum Glycemic Control With Insulin Infusion Versus Rotating Fluids

A NA study of Gestational Diabetes Mellitus and Type II Diabetes Mellitus, sponsored by Geisinger Clinic.

Completed
Registry status
NA
Development phase
114
Enrollment target
2
Study locations

NCT03912363: Completed NA study of Gestational Diabetes Mellitus and Type II Diabetes Mellitus, sponsored by Geisinger Clinic.

NCT03912363 is a NA study of Gestational Diabetes Mellitus and Type II Diabetes Mellitus that has completed, run by Geisinger Clinic. The registered enrollment target is 114 participants, below the 412-participant average among 16 other Gestational Diabetes Mellitus trials with a reported enrollment target (72% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03912363, a NA study of Gestational Diabetes Mellitus and Type II Diabetes Mellitus, has completed, sponsored by Geisinger Clinic.

COMPLETED
Registry status
NA
Development phase
114 participants
Enrollment target
2
Study locations

Study Summary

This study will determine whether rotating intravenous (IV) fluid is better than receiving insulin to control a baby's blood sugar after delivery in laboring women with diabetes. A computer will choose the method of controlling the participant's blood sugar while they are in labor.

Primary Outcome

Neonatal blood glucose value from birth to 2 hours of life

Interventions

  • OTHER Rotating fluids protocol
  • OTHER Insulin infusion protocol

Study Locations (2)

Pennsylvania

  • Geisinger - Danville
  • Geisinger Wyoming Valley - Wilkes-Barre

Trial Details

FieldValue
Enrollment Target 114 participants
Start Date 2019-11-01
Est. Completion 2025-03-01
Phase NA
Geisinger Clinic

107 total trials

What the finished NCT03912363 record still lists

NCT03912363 is an interventional study that assigns participants to a tested intervention. The registered 114 participants enrollment target is mid-sized for trials with a published cap, below the 412-participant average among 16 other Gestational Diabetes Mellitus trials with a reported enrollment target (72% lower).

The record links to 2 conditions, with Gestational Diabetes Mellitus appearing as the primary indexed condition, and to 2 interventions - of which Rotating fluids protocol is the first listed.

NCT03912363 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT03912363 about?

NCT03912363 is a clinical study titled "Intrapartum Glycemic Control With Insulin Infusion Versus Rotating Fluids". This study will determine whether rotating intravenous (IV) fluid is better than receiving insulin to control a baby's blood sugar after delivery in laboring women with diabetes. A computer will choose the method of controlling the participant's blood sugar while they are in labor.

What is the current status of trial NCT03912363?

This trial is currently completed. It is a NA study. The enrollment target is 114 participants. The study started on 2019-11-01. Estimated completion is 2025-03-01.

What conditions does trial NCT03912363 study?

This clinical trial studies the following conditions: Gestational Diabetes Mellitus, Type II Diabetes Mellitus.

What interventions are being tested in trial NCT03912363?

The interventions under investigation include: Rotating fluids protocol (OTHER), Insulin infusion protocol (OTHER).

Who is sponsoring clinical trial NCT03912363?

This trial is sponsored by Geisinger Clinic, which has 107 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03912363 being conducted?

This trial has 2 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Gestational Diabetes Mellitus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03912363's enrollment target sits among peer trials

114 13th of 16 higher than 4 of 16 other Gestational Diabetes Mellitus trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Gestational Diabetes Mellitus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04522791 · 114 participants · Phase 2

    Breathing, Relaxation, Attention Training, & Health in Older Adults (BREATHE)

  • NCT04875052 · 114 participants · NA

    Vibration and Post-traumatic Osteoarthritis Risk Following ACL Injury

  • NCT05100342 · 114 participants

    Prospective Validation of a Points Score System Predicting 30-day Survival

  • NCT05224089 · 114 participants · Phase 4

    Bilateral TAP and RS Blocks Using Liposomal Bupivacaine/Bupivacaine vs. Regular Bupivacaine in Laparoscopic Colectomy

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03912363, the US trial registry maintained by the National Library of Medicine. NCT03912363 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.